Biometrix

Company Overview

Snapshot

Founded in November 1984, Biometrix operated with 51–200 employees, developing medical devices for critical care and operating rooms. The company was acquired by Degania Medical in May 2012.

Business overview

Biometrix develops, manufactures, and markets medical devices for intensive care, surgery, and interventional cardiology. The company provides single-use solutions for various healthcare settings, including operating rooms, anesthesia, cardiothoracic, intensive care and emergency units, drug delivery, cath labs, and home care. Its product lines, such as Centra-Line, Art-Line, Urimetrix, Infu-Line, Biovac, Thorametrix, Angio-Line, and G-BUTTON, serve the Health Tech & Life Sciences sector, focusing on Medical Devices, Medical Treatment & Therapeutics, and Life Support.

Company Intelligence Q&A

What is Biometrix's primary focus?

Biometrix specializes in developing, manufacturing, and marketing medical devices for critical care, surgery, and interventional cardiology, providing single-use solutions for various healthcare environments.

When was Biometrix founded?

Biometrix was founded in November 1984.

Which company acquired Biometrix?

Biometrix was acquired by Degania Medical in May 2012.

What types of products does Biometrix offer?

Biometrix offers a range of products including Centra-Line for central venous access, Art-Line for invasive blood pressure monitoring, Urimetrix for urine meter systems, Infu-Line for specialty IV sets, Biovac for wound drainage, Thorametrix for chest drainage, Angio-Line for interventional cardiology, and the G-BUTTON for feeding and medication access.

In which sectors does Biometrix primarily operate?

Biometrix operates within the Health Tech & Life Sciences sector, with a focus on Medical Devices, Medical Treatment & Therapeutics, and Life Support.